Literature DB >> 19484764

DNA repair polymorphisms associated with cytogenetic subgroups in B-cell chronic lymphocytic leukemia.

Christina Ganster1, Jürgen Neesen, Sonja Zehetmayer, Ulrich Jäger, Harald Esterbauer, Christine Mannhalter, Britta Kluge, Christa Fonatsch.   

Abstract

Genetic polymorphisms in DNA repair genes can affect the risk of developing different forms of cancer. Therefore, we have studied the putative association of seven single nucleotide polymorphisms (SNPs) in five DNA repair genes with the incidence of chronic lymphocytic leukemia (CLL). We included 461 CLL patients and the same number of age- and sex-matched controls. As chromosomal aberrations are important prognostic markers in CLL, we additionally correlated the SNPs with the occurrence of favorable and unfavorable cytogenetic aberrations in CLL patients. Patients with del(13q) as a sole aberration were allocated to the favorable cytogenetic risk group, and patients with del(17p) and/or del(11q) to the unfavorable cytogenetic risk group. All investigated SNPs were equally distributed between patients with the favorable cytogenetic aberration and controls. However, differences were observed in the distribution of rs13181 in ERCC2 between all CLL patients and controls. Moreover, the clearest differences were found for rs13181 in ERCC2 and rs25487 in XRCC1 between CLL patients with unfavorable cytogenetic aberrations and controls. These data suggest that inborn genetic polymorphisms may predict the outcome of CLL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19484764     DOI: 10.1002/gcc.20680

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  9 in total

1.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

2.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

3.  Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways.

Authors:  Claudia M Monroy; Andrea C Cortes; Mirtha Lopez; Elizabeth Rourke; Carol J Etzel; Anas Younes; Sara S Strom; Randa El-Zein
Journal:  Mol Carcinog       Date:  2011-03-03       Impact factor: 4.784

4.  The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.

Authors:  Liang Du; Yuqi Liu; Pei Xue; Chenxi Song; Jiani Shen; Qing He; Yuanling Peng; Xiang Tong; Lizhi Tang; Yonggang Zhang
Journal:  Tumour Biol       Date:  2015-01-27

5.  The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies.

Authors:  Xiang Tong; Jiqiao Yang; Yuanling Peng; Jiani Shen; Tianyuan Xiong; Yonggang Zhang; Hong Fan
Journal:  Tumour Biol       Date:  2013-10-06

6.  Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.

Authors:  Claudia Bănescu; Adrian P Trifa; Smaranda Demian; Erzsebeth Benedek Lazar; Delia Dima; Carmen Duicu; Minodora Dobreanu
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

7.  Associations Between XPD Lys751Gln Polymorphism and Leukemia: A Meta-Analysis.

Authors:  Min Wen; Bo Zhou; Xin Lin; Yunhua Chen; Jialei Song; Yanmei Li; Eldad Zacksenhaus; Yaacov Ben-David; Xiaojiang Hao
Journal:  Front Genet       Date:  2018-06-14       Impact factor: 4.599

8.  The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies.

Authors:  Fang Wang; Qian Zhao; Hai-Rong He; Ya-Jing Zhai; Jun Lu; Hai-Bo Hu; Jin-Song Zhou; Yong-Hua Yang; Yuan-Jie Li
Journal:  Onco Targets Ther       Date:  2015-11-06       Impact factor: 4.147

9.  Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.

Authors:  Haijun Zhang; Hang Liu; Gaofeng Jiang
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.